Found 55 hits of Enzyme Inhibition Constant Data Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Cholecystokinin receptor type A
(RAT) | BDBM50005463
((R)-1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-...)Show SMILES CN1c2ccccc2C(=N[C@H](NC(=O)c2cc3ccccc3[nH]2)C1=O)c1ccccc1 |r,c:9| Show InChI InChI=1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)/t23-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| Purchase
CHEMBL MCE KEGG PC cid PC sid PDB UniChem
Patents
Similars
| Article
| n/a | n/a | 0.0800 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50020270
((RS)-1-(4-Chloro-phenyl)-3-[2-oxo-1-(2-oxo-2-pyrro...)Show SMILES Clc1ccc(NC(=O)NC2N=C(c3ccccc3)c3ccccc3N(CC(=O)N3CCCC3)C2=O)cc1 |t:10| Show InChI InChI=1S/C28H26ClN5O3/c29-20-12-14-21(15-13-20)30-28(37)32-26-27(36)34(18-24(35)33-16-6-7-17-33)23-11-5-4-10-22(23)25(31-26)19-8-2-1-3-9-19/h1-5,8-15,26H,6-7,16-18H2,(H2,30,32,37) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 0.280 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50020270
((RS)-1-(4-Chloro-phenyl)-3-[2-oxo-1-(2-oxo-2-pyrro...)Show SMILES Clc1ccc(NC(=O)NC2N=C(c3ccccc3)c3ccccc3N(CC(=O)N3CCCC3)C2=O)cc1 |t:10| Show InChI InChI=1S/C28H26ClN5O3/c29-20-12-14-21(15-13-20)30-28(37)32-26-27(36)34(18-24(35)33-16-6-7-17-33)23-11-5-4-10-22(23)25(31-26)19-8-2-1-3-9-19/h1-5,8-15,26H,6-7,16-18H2,(H2,30,32,37) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50020269
((RS)-{3-[3-(4-Chloro-phenyl)-ureido]-2-oxo-5-pheny...)Show SMILES CCOC(=O)CN1c2ccccc2C(=NC(NC(=O)Nc2ccc(Cl)cc2)C1=O)c1ccccc1 |c:14| Show InChI InChI=1S/C26H23ClN4O4/c1-2-35-22(32)16-31-21-11-7-6-10-20(21)23(17-8-4-3-5-9-17)29-24(25(31)33)30-26(34)28-19-14-12-18(27)13-15-19/h3-15,24H,2,16H2,1H3,(H2,28,30,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50043548
(1-(4-Chloro-phenyl)-3-{1-[2-(4-methyl-piperazin-1-...)Show SMILES CN1CCN(CC1)C(=O)CN1c2ccccc2C(=NC(NC(=O)Nc2ccc(Cl)cc2)C1=O)c1ccccc1 |c:19| Show InChI InChI=1S/C29H29ClN6O3/c1-34-15-17-35(18-16-34)25(37)19-36-24-10-6-5-9-23(24)26(20-7-3-2-4-8-20)32-27(28(36)38)33-29(39)31-22-13-11-21(30)12-14-22/h2-14,27H,15-19H2,1H3,(H2,31,33,39) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50020269
((RS)-{3-[3-(4-Chloro-phenyl)-ureido]-2-oxo-5-pheny...)Show SMILES CCOC(=O)CN1c2ccccc2C(=NC(NC(=O)Nc2ccc(Cl)cc2)C1=O)c1ccccc1 |c:14| Show InChI InChI=1S/C26H23ClN4O4/c1-2-35-22(32)16-31-21-11-7-6-10-20(21)23(17-8-4-3-5-9-17)29-24(25(31)33)30-26(34)28-19-14-12-18(27)13-15-19/h3-15,24H,2,16H2,1H3,(H2,28,30,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50018287
((R)-{3-[(Naphthalene-2-carbonyl)-amino]-2-oxo-2,3,...)Show SMILES CC(C)(C)OC(=O)CN1c2ccccc2CCC(NC(=O)c2ccc3ccccc3c2)C1=O Show InChI InChI=1S/C27H28N2O4/c1-27(2,3)33-24(30)17-29-23-11-7-6-9-19(23)14-15-22(26(29)32)28-25(31)21-13-12-18-8-4-5-10-20(18)16-21/h4-13,16,22H,14-15,17H2,1-3H3,(H,28,31) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 7.5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50043548
(1-(4-Chloro-phenyl)-3-{1-[2-(4-methyl-piperazin-1-...)Show SMILES CN1CCN(CC1)C(=O)CN1c2ccccc2C(=NC(NC(=O)Nc2ccc(Cl)cc2)C1=O)c1ccccc1 |c:19| Show InChI InChI=1S/C29H29ClN6O3/c1-34-15-17-35(18-16-34)25(37)19-36-24-10-6-5-9-23(24)26(20-7-3-2-4-8-20)32-27(28(36)38)33-29(39)31-22-13-11-21(30)12-14-22/h2-14,27H,15-19H2,1H3,(H2,31,33,39) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281723
(CHEMBL34335 | [2-Oxo-3-(3-m-tolyl-ureido)-2,3,4,5-...)Show SMILES Cc1cccc(NC(=O)NC2CCc3ccccc3N(CC(=O)OC(C)(C)C)C2=O)c1 Show InChI InChI=1S/C24H29N3O4/c1-16-8-7-10-18(14-16)25-23(30)26-19-13-12-17-9-5-6-11-20(17)27(22(19)29)15-21(28)31-24(2,3)4/h5-11,14,19H,12-13,15H2,1-4H3,(H2,25,26,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281722
(CHEMBL423278 | {3-[3-(3-Methoxy-phenyl)-ureido]-2-...)Show SMILES COc1cccc(NC(=O)NC2CCc3ccccc3N(CC(=O)OC(C)(C)C)C2=O)c1 Show InChI InChI=1S/C24H29N3O5/c1-24(2,3)32-21(28)15-27-20-11-6-5-8-16(20)12-13-19(22(27)29)26-23(30)25-17-9-7-10-18(14-17)31-4/h5-11,14,19H,12-13,15H2,1-4H3,(H2,25,26,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281717
(1-(3-Methoxy-phenyl)-3-[(R)-2-oxo-1-(2-oxo-2-pyrro...)Show SMILES COc1cccc(NC(=O)N[C@@H]2CCc3ccccc3N(CC(=O)N3CCCC3)C2=O)c1 Show InChI InChI=1S/C24H28N4O4/c1-32-19-9-6-8-18(15-19)25-24(31)26-20-12-11-17-7-2-3-10-21(17)28(23(20)30)16-22(29)27-13-4-5-14-27/h2-3,6-10,15,20H,4-5,11-14,16H2,1H3,(H2,25,26,31)/t20-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281726
(1-[(R)-2-Oxo-1-(2-oxo-2-pyrrolidin-1-yl-ethyl)-2,3...)Show SMILES Cc1cccc(NC(=O)N[C@@H]2CCc3ccccc3N(CC(=O)N3CCCC3)C2=O)c1 Show InChI InChI=1S/C24H28N4O3/c1-17-7-6-9-19(15-17)25-24(31)26-20-12-11-18-8-2-3-10-21(18)28(23(20)30)16-22(29)27-13-4-5-14-27/h2-3,6-10,15,20H,4-5,11-14,16H2,1H3,(H2,25,26,31)/t20-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281720
(1-[(S)-2-Oxo-1-(2-oxo-2-pyrrolidin-1-yl-ethyl)-2,3...)Show SMILES Cc1cccc(NC(=O)N[C@H]2CCc3ccccc3N(CC(=O)N3CCCC3)C2=O)c1 Show InChI InChI=1S/C24H28N4O3/c1-17-7-6-9-19(15-17)25-24(31)26-20-12-11-18-8-2-3-10-21(18)28(23(20)30)16-22(29)27-13-4-5-14-27/h2-3,6-10,15,20H,4-5,11-14,16H2,1H3,(H2,25,26,31)/t20-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281722
(CHEMBL423278 | {3-[3-(3-Methoxy-phenyl)-ureido]-2-...)Show SMILES COc1cccc(NC(=O)NC2CCc3ccccc3N(CC(=O)OC(C)(C)C)C2=O)c1 Show InChI InChI=1S/C24H29N3O5/c1-24(2,3)32-21(28)15-27-20-11-6-5-8-16(20)12-13-19(22(27)29)26-23(30)25-17-9-7-10-18(14-17)31-4/h5-11,14,19H,12-13,15H2,1-4H3,(H2,25,26,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281717
(1-(3-Methoxy-phenyl)-3-[(R)-2-oxo-1-(2-oxo-2-pyrro...)Show SMILES COc1cccc(NC(=O)N[C@@H]2CCc3ccccc3N(CC(=O)N3CCCC3)C2=O)c1 Show InChI InChI=1S/C24H28N4O4/c1-32-19-9-6-8-18(15-19)25-24(31)26-20-12-11-17-7-2-3-10-21(17)28(23(20)30)16-22(29)27-13-4-5-14-27/h2-3,6-10,15,20H,4-5,11-14,16H2,1H3,(H2,25,26,31)/t20-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 103 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281726
(1-[(R)-2-Oxo-1-(2-oxo-2-pyrrolidin-1-yl-ethyl)-2,3...)Show SMILES Cc1cccc(NC(=O)N[C@@H]2CCc3ccccc3N(CC(=O)N3CCCC3)C2=O)c1 Show InChI InChI=1S/C24H28N4O3/c1-17-7-6-9-19(15-17)25-24(31)26-20-12-11-18-8-2-3-10-21(18)28(23(20)30)16-22(29)27-13-4-5-14-27/h2-3,6-10,15,20H,4-5,11-14,16H2,1H3,(H2,25,26,31)/t20-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 109 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281723
(CHEMBL34335 | [2-Oxo-3-(3-m-tolyl-ureido)-2,3,4,5-...)Show SMILES Cc1cccc(NC(=O)NC2CCc3ccccc3N(CC(=O)OC(C)(C)C)C2=O)c1 Show InChI InChI=1S/C24H29N3O4/c1-16-8-7-10-18(14-16)25-23(30)26-19-13-12-17-9-5-6-11-20(17)27(22(19)29)15-21(28)31-24(2,3)4/h5-11,14,19H,12-13,15H2,1-4H3,(H2,25,26,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281718
(CHEMBL424211 | {3-[3-(4-Chloro-phenyl)-ureido]-2-o...)Show SMILES CC(C)(C)OC(=O)CN1c2ccccc2CCC(NC(=O)Nc2ccc(Cl)cc2)C1=O Show InChI InChI=1S/C23H26ClN3O4/c1-23(2,3)31-20(28)14-27-19-7-5-4-6-15(19)8-13-18(21(27)29)26-22(30)25-17-11-9-16(24)10-12-17/h4-7,9-12,18H,8,13-14H2,1-3H3,(H2,25,26,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281720
(1-[(S)-2-Oxo-1-(2-oxo-2-pyrrolidin-1-yl-ethyl)-2,3...)Show SMILES Cc1cccc(NC(=O)N[C@H]2CCc3ccccc3N(CC(=O)N3CCCC3)C2=O)c1 Show InChI InChI=1S/C24H28N4O3/c1-17-7-6-9-19(15-17)25-24(31)26-20-12-11-18-8-2-3-10-21(18)28(23(20)30)16-22(29)27-13-4-5-14-27/h2-3,6-10,15,20H,4-5,11-14,16H2,1H3,(H2,25,26,31)/t20-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281723
(CHEMBL34335 | [2-Oxo-3-(3-m-tolyl-ureido)-2,3,4,5-...)Show SMILES Cc1cccc(NC(=O)NC2CCc3ccccc3N(CC(=O)OC(C)(C)C)C2=O)c1 Show InChI InChI=1S/C24H29N3O4/c1-16-8-7-10-18(14-16)25-23(30)26-19-13-12-17-9-5-6-11-20(17)27(22(19)29)15-21(28)31-24(2,3)4/h5-11,14,19H,12-13,15H2,1-4H3,(H2,25,26,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281725
(CHEMBL355319 | [3-(3-Naphthalen-1-yl-ureido)-2-oxo...)Show SMILES CC(C)(C)OC(=O)CN1c2ccccc2CCC(NC(=O)Nc2cccc3ccccc23)C1=O Show InChI InChI=1S/C27H29N3O4/c1-27(2,3)34-24(31)17-30-23-14-7-5-10-19(23)15-16-22(25(30)32)29-26(33)28-21-13-8-11-18-9-4-6-12-20(18)21/h4-14,22H,15-17H2,1-3H3,(H2,28,29,33) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281720
(1-[(S)-2-Oxo-1-(2-oxo-2-pyrrolidin-1-yl-ethyl)-2,3...)Show SMILES Cc1cccc(NC(=O)N[C@H]2CCc3ccccc3N(CC(=O)N3CCCC3)C2=O)c1 Show InChI InChI=1S/C24H28N4O3/c1-17-7-6-9-19(15-17)25-24(31)26-20-12-11-18-8-2-3-10-21(18)28(23(20)30)16-22(29)27-13-4-5-14-27/h2-3,6-10,15,20H,4-5,11-14,16H2,1H3,(H2,25,26,31)/t20-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281718
(CHEMBL424211 | {3-[3-(4-Chloro-phenyl)-ureido]-2-o...)Show SMILES CC(C)(C)OC(=O)CN1c2ccccc2CCC(NC(=O)Nc2ccc(Cl)cc2)C1=O Show InChI InChI=1S/C23H26ClN3O4/c1-23(2,3)31-20(28)14-27-19-7-5-4-6-15(19)8-13-18(21(27)29)26-22(30)25-17-11-9-16(24)10-12-17/h4-7,9-12,18H,8,13-14H2,1-3H3,(H2,25,26,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50005463
((R)-1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-...)Show SMILES CN1c2ccccc2C(=N[C@H](NC(=O)c2cc3ccccc3[nH]2)C1=O)c1ccccc1 |r,c:9| Show InChI InChI=1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)/t23-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE KEGG PC cid PC sid PDB UniChem
Patents
Similars
| Article
| n/a | n/a | 245 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281722
(CHEMBL423278 | {3-[3-(3-Methoxy-phenyl)-ureido]-2-...)Show SMILES COc1cccc(NC(=O)NC2CCc3ccccc3N(CC(=O)OC(C)(C)C)C2=O)c1 Show InChI InChI=1S/C24H29N3O5/c1-24(2,3)32-21(28)15-27-20-11-6-5-8-16(20)12-13-19(22(27)29)26-23(30)25-17-9-7-10-18(14-17)31-4/h5-11,14,19H,12-13,15H2,1-4H3,(H2,25,26,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50005463
((R)-1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-...)Show SMILES CN1c2ccccc2C(=N[C@H](NC(=O)c2cc3ccccc3[nH]2)C1=O)c1ccccc1 |r,c:9| Show InChI InChI=1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)/t23-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE KEGG PC cid PC sid PDB UniChem
Patents
Similars
| Article
| n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281715
(1-(3-Methoxy-phenyl)-3-[(S)-2-oxo-1-(2-oxo-2-pyrro...)Show SMILES COc1cccc(NC(=O)N[C@H]2CCc3ccccc3N(CC(=O)N3CCCC3)C2=O)c1 Show InChI InChI=1S/C24H28N4O4/c1-32-19-9-6-8-18(15-19)25-24(31)26-20-12-11-17-7-2-3-10-21(17)28(23(20)30)16-22(29)27-13-4-5-14-27/h2-3,6-10,15,20H,4-5,11-14,16H2,1H3,(H2,25,26,31)/t20-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 335 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281718
(CHEMBL424211 | {3-[3-(4-Chloro-phenyl)-ureido]-2-o...)Show SMILES CC(C)(C)OC(=O)CN1c2ccccc2CCC(NC(=O)Nc2ccc(Cl)cc2)C1=O Show InChI InChI=1S/C23H26ClN3O4/c1-23(2,3)31-20(28)14-27-19-7-5-4-6-15(19)8-13-18(21(27)29)26-22(30)25-17-11-9-16(24)10-12-17/h4-7,9-12,18H,8,13-14H2,1-3H3,(H2,25,26,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 350 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50020269
((RS)-{3-[3-(4-Chloro-phenyl)-ureido]-2-oxo-5-pheny...)Show SMILES CCOC(=O)CN1c2ccccc2C(=NC(NC(=O)Nc2ccc(Cl)cc2)C1=O)c1ccccc1 |c:14| Show InChI InChI=1S/C26H23ClN4O4/c1-2-35-22(32)16-31-21-11-7-6-10-20(21)23(17-8-4-3-5-9-17)29-24(25(31)33)30-26(34)28-19-14-12-18(27)13-15-19/h3-15,24H,2,16H2,1H3,(H2,28,30,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 370 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281727
(1-Naphthalen-1-yl-3-[2-oxo-1-(2-oxo-2-pyrrolidin-1...)Show SMILES O=C(CN1c2ccccc2CCC(NC(=O)Nc2cccc3ccccc23)C1=O)N1CCCC1 Show InChI InChI=1S/C27H28N4O3/c32-25(30-16-5-6-17-30)18-31-24-13-4-2-9-20(24)14-15-23(26(31)33)29-27(34)28-22-12-7-10-19-8-1-3-11-21(19)22/h1-4,7-13,23H,5-6,14-18H2,(H2,28,29,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 460 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281725
(CHEMBL355319 | [3-(3-Naphthalen-1-yl-ureido)-2-oxo...)Show SMILES CC(C)(C)OC(=O)CN1c2ccccc2CCC(NC(=O)Nc2cccc3ccccc23)C1=O Show InChI InChI=1S/C27H29N3O4/c1-27(2,3)34-24(31)17-30-23-14-7-5-10-19(23)15-16-22(25(30)32)29-26(33)28-21-13-8-11-18-9-4-6-12-20(18)21/h4-14,22H,15-17H2,1-3H3,(H2,28,29,33) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 480 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50020270
((RS)-1-(4-Chloro-phenyl)-3-[2-oxo-1-(2-oxo-2-pyrro...)Show SMILES Clc1ccc(NC(=O)NC2N=C(c3ccccc3)c3ccccc3N(CC(=O)N3CCCC3)C2=O)cc1 |t:10| Show InChI InChI=1S/C28H26ClN5O3/c29-20-12-14-21(15-13-20)30-28(37)32-26-27(36)34(18-24(35)33-16-6-7-17-33)23-11-5-4-10-22(23)25(31-26)19-8-2-1-3-9-19/h1-5,8-15,26H,6-7,16-18H2,(H2,30,32,37) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 520 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281721
(1-{1-[2-(4-Methyl-piperazin-1-yl)-2-oxo-ethyl]-2-o...)Show SMILES CN1CCN(CC1)C(=O)CN1c2ccccc2CCC(NC(=O)Nc2cccc(C)c2)C1=O Show InChI InChI=1S/C25H31N5O3/c1-18-6-5-8-20(16-18)26-25(33)27-21-11-10-19-7-3-4-9-22(19)30(24(21)32)17-23(31)29-14-12-28(2)13-15-29/h3-9,16,21H,10-15,17H2,1-2H3,(H2,26,27,33) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 610 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281727
(1-Naphthalen-1-yl-3-[2-oxo-1-(2-oxo-2-pyrrolidin-1...)Show SMILES O=C(CN1c2ccccc2CCC(NC(=O)Nc2cccc3ccccc23)C1=O)N1CCCC1 Show InChI InChI=1S/C27H28N4O3/c32-25(30-16-5-6-17-30)18-31-24-13-4-2-9-20(24)14-15-23(26(31)33)29-27(34)28-22-12-7-10-19-8-1-3-11-21(19)22/h1-4,7-13,23H,5-6,14-18H2,(H2,28,29,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 650 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281720
(1-[(S)-2-Oxo-1-(2-oxo-2-pyrrolidin-1-yl-ethyl)-2,3...)Show SMILES Cc1cccc(NC(=O)N[C@H]2CCc3ccccc3N(CC(=O)N3CCCC3)C2=O)c1 Show InChI InChI=1S/C24H28N4O3/c1-17-7-6-9-19(15-17)25-24(31)26-20-12-11-18-8-2-3-10-21(18)28(23(20)30)16-22(29)27-13-4-5-14-27/h2-3,6-10,15,20H,4-5,11-14,16H2,1H3,(H2,25,26,31)/t20-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 878 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281716
(CHEMBL171722 | [2-Oxo-3-(3-m-tolyl-ureido)-2,3,4,5...)Show SMILES Cc1cccc(NC(=O)NC2CCc3ccccc3N(CC(O)=O)C2=O)c1 Show InChI InChI=1S/C20H21N3O4/c1-13-5-4-7-15(11-13)21-20(27)22-16-10-9-14-6-2-3-8-17(14)23(19(16)26)12-18(24)25/h2-8,11,16H,9-10,12H2,1H3,(H,24,25)(H2,21,22,27) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 940 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281725
(CHEMBL355319 | [3-(3-Naphthalen-1-yl-ureido)-2-oxo...)Show SMILES CC(C)(C)OC(=O)CN1c2ccccc2CCC(NC(=O)Nc2cccc3ccccc23)C1=O Show InChI InChI=1S/C27H29N3O4/c1-27(2,3)34-24(31)17-30-23-14-7-5-10-19(23)15-16-22(25(30)32)29-26(33)28-21-13-8-11-18-9-4-6-12-20(18)21/h4-14,22H,15-17H2,1-3H3,(H2,28,29,33) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 960 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281721
(1-{1-[2-(4-Methyl-piperazin-1-yl)-2-oxo-ethyl]-2-o...)Show SMILES CN1CCN(CC1)C(=O)CN1c2ccccc2CCC(NC(=O)Nc2cccc(C)c2)C1=O Show InChI InChI=1S/C25H31N5O3/c1-18-6-5-8-20(16-18)26-25(33)27-21-11-10-19-7-3-4-9-22(19)30(24(21)32)17-23(31)29-14-12-28(2)13-15-29/h3-9,16,21H,10-15,17H2,1-2H3,(H2,26,27,33) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 970 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281720
(1-[(S)-2-Oxo-1-(2-oxo-2-pyrrolidin-1-yl-ethyl)-2,3...)Show SMILES Cc1cccc(NC(=O)N[C@H]2CCc3ccccc3N(CC(=O)N3CCCC3)C2=O)c1 Show InChI InChI=1S/C24H28N4O3/c1-17-7-6-9-19(15-17)25-24(31)26-20-12-11-18-8-2-3-10-21(18)28(23(20)30)16-22(29)27-13-4-5-14-27/h2-3,6-10,15,20H,4-5,11-14,16H2,1H3,(H2,25,26,31)/t20-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281715
(1-(3-Methoxy-phenyl)-3-[(S)-2-oxo-1-(2-oxo-2-pyrro...)Show SMILES COc1cccc(NC(=O)N[C@H]2CCc3ccccc3N(CC(=O)N3CCCC3)C2=O)c1 Show InChI InChI=1S/C24H28N4O4/c1-32-19-9-6-8-18(15-19)25-24(31)26-20-12-11-17-7-2-3-10-21(17)28(23(20)30)16-22(29)27-13-4-5-14-27/h2-3,6-10,15,20H,4-5,11-14,16H2,1H3,(H2,25,26,31)/t20-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 1.19E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50043548
(1-(4-Chloro-phenyl)-3-{1-[2-(4-methyl-piperazin-1-...)Show SMILES CN1CCN(CC1)C(=O)CN1c2ccccc2C(=NC(NC(=O)Nc2ccc(Cl)cc2)C1=O)c1ccccc1 |c:19| Show InChI InChI=1S/C29H29ClN6O3/c1-34-15-17-35(18-16-34)25(37)19-36-24-10-6-5-9-23(24)26(20-7-3-2-4-8-20)32-27(28(36)38)33-29(39)31-22-13-11-21(30)12-14-22/h2-14,27H,15-19H2,1H3,(H2,31,33,39) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281727
(1-Naphthalen-1-yl-3-[2-oxo-1-(2-oxo-2-pyrrolidin-1...)Show SMILES O=C(CN1c2ccccc2CCC(NC(=O)Nc2cccc3ccccc23)C1=O)N1CCCC1 Show InChI InChI=1S/C27H28N4O3/c32-25(30-16-5-6-17-30)18-31-24-13-4-2-9-20(24)14-15-23(26(31)33)29-27(34)28-22-12-7-10-19-8-1-3-11-21(19)22/h1-4,7-13,23H,5-6,14-18H2,(H2,28,29,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281719
(CHEMBL169931 | {3-[3-(3-Methoxy-phenyl)-ureido]-2-...)Show SMILES COc1cccc(NC(=O)NC2CCc3ccccc3N(CC(O)=O)C2=O)c1 Show InChI InChI=1S/C20H21N3O5/c1-28-15-7-4-6-14(11-15)21-20(27)22-16-10-9-13-5-2-3-8-17(13)23(19(16)26)12-18(24)25/h2-8,11,16H,9-10,12H2,1H3,(H,24,25)(H2,21,22,27) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281716
(CHEMBL171722 | [2-Oxo-3-(3-m-tolyl-ureido)-2,3,4,5...)Show SMILES Cc1cccc(NC(=O)NC2CCc3ccccc3N(CC(O)=O)C2=O)c1 Show InChI InChI=1S/C20H21N3O4/c1-13-5-4-7-15(11-13)21-20(27)22-16-10-9-14-6-2-3-8-17(14)23(19(16)26)12-18(24)25/h2-8,11,16H,9-10,12H2,1H3,(H,24,25)(H2,21,22,27) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281716
(CHEMBL171722 | [2-Oxo-3-(3-m-tolyl-ureido)-2,3,4,5...)Show SMILES Cc1cccc(NC(=O)NC2CCc3ccccc3N(CC(O)=O)C2=O)c1 Show InChI InChI=1S/C20H21N3O4/c1-13-5-4-7-15(11-13)21-20(27)22-16-10-9-14-6-2-3-8-17(14)23(19(16)26)12-18(24)25/h2-8,11,16H,9-10,12H2,1H3,(H,24,25)(H2,21,22,27) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281719
(CHEMBL169931 | {3-[3-(3-Methoxy-phenyl)-ureido]-2-...)Show SMILES COc1cccc(NC(=O)NC2CCc3ccccc3N(CC(O)=O)C2=O)c1 Show InChI InChI=1S/C20H21N3O5/c1-28-15-7-4-6-14(11-15)21-20(27)22-16-10-9-13-5-2-3-8-17(13)23(19(16)26)12-18(24)25/h2-8,11,16H,9-10,12H2,1H3,(H,24,25)(H2,21,22,27) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 3.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281721
(1-{1-[2-(4-Methyl-piperazin-1-yl)-2-oxo-ethyl]-2-o...)Show SMILES CN1CCN(CC1)C(=O)CN1c2ccccc2CCC(NC(=O)Nc2cccc(C)c2)C1=O Show InChI InChI=1S/C25H31N5O3/c1-18-6-5-8-20(16-18)26-25(33)27-21-11-10-19-7-3-4-9-22(19)30(24(21)32)17-23(31)29-14-12-28(2)13-15-29/h3-9,16,21H,10-15,17H2,1-2H3,(H2,26,27,33) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281724
(1-{1-[2-(4-Methyl-piperazin-1-yl)-2-oxo-ethyl]-2-o...)Show SMILES CN1CCN(CC1)C(=O)CN1c2ccccc2CCC(NC(=O)Nc2cccc3ccccc23)C1=O Show InChI InChI=1S/C28H31N5O3/c1-31-15-17-32(18-16-31)26(34)19-33-25-12-5-3-8-21(25)13-14-24(27(33)35)30-28(36)29-23-11-6-9-20-7-2-4-10-22(20)23/h2-12,24H,13-19H2,1H3,(H2,29,30,36) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 5.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281724
(1-{1-[2-(4-Methyl-piperazin-1-yl)-2-oxo-ethyl]-2-o...)Show SMILES CN1CCN(CC1)C(=O)CN1c2ccccc2CCC(NC(=O)Nc2cccc3ccccc23)C1=O Show InChI InChI=1S/C28H31N5O3/c1-31-15-17-32(18-16-31)26(34)19-33-25-12-5-3-8-21(25)13-14-24(27(33)35)30-28(36)29-23-11-6-9-20-7-2-4-10-22(20)23/h2-12,24H,13-19H2,1H3,(H2,29,30,36) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 5.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-gastrin to gastric glands in guinea pig. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281728
(CHEMBL170068 | [3-(3-Naphthalen-1-yl-ureido)-2-oxo...)Show SMILES OC(=O)CN1c2ccccc2CCC(NC(=O)Nc2cccc3ccccc23)C1=O Show InChI InChI=1S/C23H21N3O4/c27-21(28)14-26-20-11-4-2-7-16(20)12-13-19(22(26)29)25-23(30)24-18-10-5-8-15-6-1-3-9-17(15)18/h1-11,19H,12-14H2,(H,27,28)(H2,24,25,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281719
(CHEMBL169931 | {3-[3-(3-Methoxy-phenyl)-ureido]-2-...)Show SMILES COc1cccc(NC(=O)NC2CCc3ccccc3N(CC(O)=O)C2=O)c1 Show InChI InChI=1S/C20H21N3O5/c1-28-15-7-4-6-14(11-15)21-20(27)22-16-10-9-13-5-2-3-8-17(13)23(19(16)26)12-18(24)25/h2-8,11,16H,9-10,12H2,1H3,(H,24,25)(H2,21,22,27) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 8.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50018287
((R)-{3-[(Naphthalene-2-carbonyl)-amino]-2-oxo-2,3,...)Show SMILES CC(C)(C)OC(=O)CN1c2ccccc2CCC(NC(=O)c2ccc3ccccc3c2)C1=O Show InChI InChI=1S/C27H28N2O4/c1-27(2,3)33-24(30)17-29-23-11-7-6-9-19(23)14-15-22(26(29)32)28-25(31)21-13-12-18-8-4-5-10-20(18)16-21/h4-13,16,22H,14-15,17H2,1-3H3,(H,28,31) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(Homo sapiens (Human)) | BDBM50281728
(CHEMBL170068 | [3-(3-Naphthalen-1-yl-ureido)-2-oxo...)Show SMILES OC(=O)CN1c2ccccc2CCC(NC(=O)Nc2cccc3ccccc23)C1=O Show InChI InChI=1S/C23H21N3O4/c27-21(28)14-26-20-11-4-2-7-16(20)12-13-19(22(26)29)25-23(30)24-18-10-5-8-15-6-1-3-9-17(15)18/h1-11,19H,12-14H2,(H,27,28)(H2,24,25,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig cortex. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281728
(CHEMBL170068 | [3-(3-Naphthalen-1-yl-ureido)-2-oxo...)Show SMILES OC(=O)CN1c2ccccc2CCC(NC(=O)Nc2cccc3ccccc23)C1=O Show InChI InChI=1S/C23H21N3O4/c27-21(28)14-26-20-11-4-2-7-16(20)12-13-19(22(26)29)25-23(30)24-18-10-5-8-15-6-1-3-9-17(15)18/h1-11,19H,12-14H2,(H,27,28)(H2,24,25,30) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281724
(1-{1-[2-(4-Methyl-piperazin-1-yl)-2-oxo-ethyl]-2-o...)Show SMILES CN1CCN(CC1)C(=O)CN1c2ccccc2CCC(NC(=O)Nc2cccc3ccccc23)C1=O Show InChI InChI=1S/C28H31N5O3/c1-31-15-17-32(18-16-31)26(34)19-33-25-12-5-3-8-21(25)13-14-24(27(33)35)30-28(36)29-23-11-6-9-20-7-2-4-10-22(20)23/h2-12,24H,13-19H2,1H3,(H2,29,30,36) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article
| n/a | n/a | 3.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Ability to inhibit the binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreas. |
Bioorg Med Chem Lett 3: 871-874 (1993)
Article DOI: 10.1016/S0960-894X(00)80683-6 BindingDB Entry DOI: 10.7270/Q2513Z41 |
More data for this Ligand-Target Pair | |